Clinical Trials

Study Title:
A Phase III, Multicenter, Open label Study of Ribociclib vs. Palbociclib in Patients With Advanced Hormone Receptor positive/HER2 negative/HER2 Enriched Breast Cancer HARMONIA Trial

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Frank Brescia, at bresciaf@musc.edu. Study Coordinator, Margaret (Maggie) Scott, at scotmarg@musc.edu. Trial opened at the following institutions: Medical University of South Carolina